P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritis

Journal of the American Society of Nephrology

Volumn 18, Issue 2, 2007, Pages 494-505

  Hohenstein, Bernd ^a   Renk, Sindy ^a   Lang, Kathrin ^a   Daniel, Christoph ^a   Freund, Monique ^b,c   Léon, Catherine ^b,c   Amann, Kerstin U ^a   Gachet, Christian ^b,c   Hugo, Christian P M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b INSERM   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; PURINE P2Y1 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; GENE; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; KIDNEY TUBULE DAMAGE; MALE; MESANGIUM CELL; MOUSE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; P2Y1 GENE; PASSIVE CRESCENTIC GLOMERULONEPHRITIS; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; THROMBOCYTE ACTIVATION; WILD TYPE;

EID: 33846655747     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006050439     Document Type: Article

References (50)

1. Ralevic V, Burnstock G: Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998
2. Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Cachet C: Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 104: 1731-1737, 1999
3. Wang L, Jacobsen SE, Bengtsson A, Erlinge D: P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5: 16, 2004
4. Burnstock G: Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22: 364-373, 2002
5. Bailey MA, Turner CM, Hus-Citharel A, Marchetti J, Imbert-Teboul M, Milner P, Burnstock G, Unwin RJ: P2Y receptors present in the native and isolated rat glomerulus. Nephron Physiol 96: 79-90, 2004
6. Gachet C, Hechler B: The platelet P2 receptors in thrombosis. Semin Thromb Haemost 31: 162-167, 2005
7. Geary C, Akinbi H, Korfhagen T, Fabre JE, Boucher R, Rice W: Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 289: L890-L895, 2005
8. Luttikhuizen DT, Harmsen MC, de Leij LF, van Luyn MJ: Expression of P2 receptors at sites of chronic inflammation. Cell Tissue Res 317: 289-298, 2004
9. Di Virgilio F, Baricordi OR, Romagnoli R, Baraldi PG: Leukocyte P2 receptors: A novel target for anti-inflammatory and anti-tumor therapy. Curr Drug Targets Cardiovasc Haematol Disord 5: 85-99, 2005
10. Di Virgilio F, Ferrari D, Falzoni S, Chiozzi P, Munerati M, Steinberg TH, Baricordi OR: P2 purinoceptors in the immune system. Ciba Found Symp 198: 290-302; discussion 302-305, 1996
11. Johnson RJ: Platelets in inflammatory glomerular injury. Semin Nephrol 11: 276-284, 1991
12. Barnes JL: Platelets in glomerular disease. Nephron 77: 378-393, 1997
13. Johnson RJ, Garcia RL, Pritzl P, Alpers CE: Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 136: 369-374, 1990
14. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ: Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13: 806-816, 2002
15. Ostendorf T, Kunter U, Eitner F, Loos A, Regele H, Kerjaschki D, Henninger DD, Janjic N, Floege J: VEGF(165) mediates glomerular endothelial repair. J Clin Invest 104: 913-923, 1999
16. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12: 1434-1447, 2001
17. Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N: Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 159: 599-608, 2001
18. Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ: Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 147: 1715-1727, 1995
19. Ophascharoensuk V, Pippin JW, Gordon KL, Shankland SJ, Couser WG, Johnson RJ: Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 54: 416-425, 1998
20. el Nahas AM, Bassett AH, Cope GH, Le Carpentier JE: Role of growth hormone in the development of experimental renal scarring. Kidney Int 40: 29-34, 1991
21. Hugo C, Pichler R, Meek R, Gordon K, Kyriakides T, Floege J, Bornstein P, Couser WG, Johnson RJ: Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int 48: 1846-1856, 1995
22. Hallmann R, Mayer DN, Berg EL, Broermann R, Butcher EC: Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier. Dev Dyn 202: 325-332, 1995
23. Thurston G, Murphy TJ, Baluk P, Lindsey JR, McDonald DM: Angiogenesis in mice with chronic airway inflammation: Strain-dependent differences. Am J Pathol 153: 1099-1112, 1998
24. Baurand A, Eckly A, Bari N, Leon C, Hechler B, Cazenave JP, Gachet C: Desensitization of the platelet aggregation response to ADP: Differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost 84: 484-491, 2000
25. Moran-Jimenez MJ, Matute C: Immunohistochemical localization of the P2Y(1) purinergic receptor in neurons and glial cells of the central nervous system. Brain Res Mol Brain Res 78: 50-58, 2000
26. Bergmeier W, Rackebrandt K, Schroder W, Zirngibl H, Nieswandt B: Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies. Blood 95: 886-893, 2000
27. Hohenstein B, Kasperek L, Kobelt DJ, Daniel C, Gambaryan S, Renne T, Walter U, Amann KU, Hugo CP: Vasodilator-stimulated phosphoprotein-deficient mice demonstrate increased platelet activation but improved renal endothelial preservation and regeneration in passive nephrotoxic nephritis. J Am Soc Nephrol 16: 986-996, 2005
28. Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ: Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 58: 2390-2399, 2000
29. Hugo C, Shankland SJ, Bowen-Pope DF, Couser WG, Johnson RJ: Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus. J Clin Invest 100: 786-794, 1997
30. Hughes J, Brown P, Shankland SJ: Cyclin kinase inhibitor p21CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction. Am J Physiol 277: F948-F956, 1999
31. Weibel ER: Practical Methods for Biological Morphometry, London, Academic Press, 1979
32. Weibel ER: Theoretical Foundations. London, Academic Press 1979
33. Amann K, Koch A, Hofstetter J, Gross ML, Haas C, Orth SR, Ehmke H, Rump LC, Ritz E: Glomerulosclerosis and progression: Effect of subantihypertensive doses of alpha and beta blockers. Kidney Int 60: 1309-1323, 2001
34. Hahne M, Jager U, Isenmann S, Hallmann R, Vestweber D: Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes. J Cell Biol 121: 655-664, 1993
35. Li ZD, Bork JP, Krueger B, Patsenker E, Schulze-Krebs A, Hahn EG, Schuppan D: VEGF induces proliferation, migration, and TGF-beta1 expression in mouse glomerular endothelial cells via mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Biochem Biophys Res Commun 334: 1049-1060, 2005
36. Schiwek D, Endlich N, Holzman L, Holthofer H, Kriz W, Endlich K: Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines. Kidney Int 66: 91-101, 2004
37. Calvert JA, Atterbury-Thomas AE, Leon C, Forsythe ID, Gachet C, Evans RJ: Evidence for P2Y1, P2Y2, P2Y6 and atypical UTP-sensitive receptors coupled to rises in intracellular calcium in mouse cultured superior cervical ganglion neurons and glia. Br J Pharmacol 143: 525-532, 2004
38. Wang L, Karlsson L, Moses S, Hultgardh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D: P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40: 841-853, 2002
39. Fischer KG, Saueressig U, Jacobshagen C, Wichelmann A, Pavenstadt H: Extracellular nucleotides regulate cellular functions of podocytes in culture. Am J Physiol Renal Physiol 281: F1075-F1081, 2001
40. Vonend O, Grote T, Oberhauser V, Von Kugelgen I, Rump LC: P2Y-receptors stimulating the proliferation of human mesangial cells through the MAPK42/44 pathway. Br J Pharmacol 139: 1119-1126, 2003
41. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am J Pathol 151: 1231-1239, 1997
42. Goepfert C, Imai M, Brouard S, Csizmadia E, Kaczmarek E, Robson SC: CD39 modulates endothelial cell activation and apoptosis. Mol Med 6: 591-603, 2000
43. Czajkowski R, Banachewicz W, Ilnytska O, Drobot LB, Baranska J: Differential effects of P2Y1 and P2Y12 nucleotide receptors on ERK1/ERK2 and phosphatidylinositol 3-kinase signalling and cell proliferation in serum-deprived and nonstarved glioma C6 cells. Br J Pharmacol 141: 497-507, 2004
44. Sellers LA, Simon J, Lundahl TS, Cousens DJ, Humphrey PP, Barnard EA: Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis. J Biol Chem 276: 16379-16390, 2001
45. da Silva CG, Jarzyna R, Specht A, Kaczmarek E: Extracellular nucleotides and adenosine independently activate AMP-activated protein kinase in endothelial cells: Involvement of P2 receptors and adenosine transporters. Circ Res 98: e39-e47, 2006
46. Nagata D, Mogi M, Walsh K: AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 278: 31000-31006, 2003
47. Buvinic S, Briones R, Huidobro-Toro JP: P2Y1 and P2Y1 receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed. Br J Pharmacol 136: 847-856, 2002
48. Isenberg JS: Nitric oxide modulation of early angiogenesis. Microsurgery 24: 385-391, 2004
49. Kang DH, Johnson RJ: Vascular endothelial growth factor: A new player in the pathogenesis of renal fibrosis. Curr Opin Nephrol Hypertens 12: 43-49, 2003
50. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12: 1448-1457, 2001